AMOXIL is indicated in the treatment of infections due to susceptible (ONLY β-lactamase–
negative) strains of the designated microorganisms in the conditions listed below:
*Infections of the ear, nose, and throat – due to Streptococcus spp. (α- and β-hemolytic strains
only), S. pneumoniae, Staphylococcus spp., or H. influenzae.
*Infections of the genitourinary tract – due to E. coli, P. mirabilis, or E. faecalis.
*Infections of the skin and skin structure – due to Streptococcus spp. (α- and β-hemolytic
strains only), Staphylococcus spp., or E. coli.
*Infections of the lower respiratory tract – due to Streptococcus spp. (α- and β-hemolytic
strains only), S. pneumoniae, Staphylococcus spp., or H. influenzae.
*Gonorrhea, acute uncomplicated (ano-genital and urethral infections) – due to
N. gonorrhoeae (males and females).
*H. pylori eradication to reduce the risk of duodenal ulcer recurrence
